The vision

"Advances in toxicogenomics, bioinformatics, systems biology, epigenetics, and computational toxicology could transform toxicity testing from a system based on whole-animal testing to one founded primarily on in vitro methods that evaluate changes in biologic processes using cells, cell lines, or cellular components, preferably of human origin."

[Toxicity Testing in the 21st Century: A Vision and a Strategy (2007)]

Objectives & Scope

The aim of the workshop is to explore the potential of omics technologies for informing cancer risk assessment. The focus is on unclear risks, i.e. on risks where not enough evidence exists for a conclusive risk characterization. The main issue is whether in such cases omics might add critical information to the available classical genotoxicity studies in order to improve the risk assessment. The unclear risk chosen for discussion is RF EMF.

The organizers are especially interested in bringing together experts with different scientific backgrounds and views in order to stimulate an open discussion about the pros and cons of omics for assessing unclear risks.

Target Groups

The workshop will bring together researchers from omics and genotoxicity research, as well as researchers specialized in RF EMF animal and epidemiological studies. Special efforts will be made to motivate young scientists who are interested in the issues discussed in the workshop. The workshop is open to all interested parties and stakeholders.